![Harold Selick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Harold Selick
Président chez
PROTAGONIST THERAPEUTICS, INC.
Fortune : 7 M $ au 30/06/2026
Profil
Harold E.
Selick is the founder of Epiphany Biosciences, Inc., founded in 2001.
Dr. Selick was the founder of Camitro UK Ltd., founded in 1999, and served as Chairman from 1999 to 2014.
Dr. Selick is also the founder of ArQule UK Ltd...
Dr. Selick is Chief Executive Officer & Director at Hinge Bio, Inc. since 2023.
Dr. Selick is Chairman at Protagonist Therapeutics, Inc. since 2014.
Dr. Selick is Independent Director at Protagonist Pty Ltd. Dr. Selick is Director at Molecular Templates OpCo, Inc. Dr. Selick is Venture Partner at Mission Bay Capital Management, Inc. Former positions include Chairman & Chief Executive Officer at Threshold Pharmaceuticals, Inc. from 2002 to 2017; President & Chief Executive Officer at Camitro Corp.
from 1999 to 2002; Chairman at DiObex, Inc.; Chairman at Catalyst Bioscience, Inc. from 2003 to 2015 and from 2015 to 2018; Chairman at PDL BioPharma, Inc. from 2009 to 2019; Chairman at Molecular Templates, Inc. from 2017 to 2024; Director at Amunix Pharmaceuticals, Inc.; Director at Amunix, Inc.; Staff Scientist at Protein Design Labs, Inc. from 1983 to 1985; Principal at Anergen, Inc.; Vice President-Research at Glaxo Wellcome Plc; Partner at Sofinnova Investments, Inc. from 2002 to 2007; Vice President-Research at Affymax Research Institute from 1992 to 2002; Vice Chancellor-Business Development & Innovation at The University of California, San Francisco from 2017 to 2022.
Education includes undergraduate and doctorate degrees from the University of Pennsylvania.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/03/2026 | 60 845 ( 0,09 % ) | 7 M $ | 30/06/2026 |
Postes actifs de Harold Selick
| Sociétés | Poste | Début |
|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Président | 19/03/2014 |
Mission Bay Capital Management, Inc.
 Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital invests in companies located in the United States. The firm focuses on the biotechnology and life sciences sector. It participates in early stage capital transactions. Mission Bay Capital reorganized its operating segments on January 21,2020, by combining BioInnovation Management LLC and Mission Bay Capital Management Inc into a single segment called - Mission BioCapital. | Private Equity Investor | - |
Molecular Templates OpCo, Inc.
 Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Functions as an investment holding company | Directeur/Membre du Conseil | - |
Protagonist Pty Ltd.
 Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company | Président | - |
Hinge Bio, Inc.
 Hinge Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for autoimmune and inflammatory & cancer diseases | Directeur Général | 18/01/2023 |
Anciens postes connus de Harold Selick
| Sociétés | Poste | Fin |
|---|---|---|
| MOLECULAR TEMPLATES, INC. | Président | 31/12/2024 |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/12/2022 |
| PDL BIOPHARMA, INC. | Président | 31/12/2019 |
| CATALYST BIOSCIENCES | Président | 15/02/2018 |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Harold Selick
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
65
Relations au 1er degré
24
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 24 |
|---|---|
Protein Design Labs, Inc.
 Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops humanized monoclonal antibodies | Health Technology |
Anergen, Inc.
 Anergen, Inc. BiotechnologyHealth Technology Develops propriety therapeutics designed to interrupt the antigen process | Health Technology |
Glaxo Wellcome Plc
 Glaxo Wellcome Plc Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and markets pharmaceuticals | Health Technology |
Threshold Pharmaceuticals, Inc.
 Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
DiObex, Inc.
 DiObex, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for metabolic disease treatment | Health Technology |
Catalyst Bioscience, Inc. /Old/
 Catalyst Bioscience, Inc. /Old/ Medical SpecialtiesHealth Technology Develops and markets catalytic biopharmaceutical products | Health Technology |
Protagonist Pty Ltd.
Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company | Health Technology |
Epiphany Biosciences, Inc.
 Epiphany Biosciences, Inc. Medical SpecialtiesHealth Technology Develops therapeutic products and diagnostic technologies | Health Technology |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Finance |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Affymax Research Institute
 Affymax Research Institute Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
Camitro Corp.
 Camitro Corp. Miscellaneous Commercial ServicesCommercial Services Develops and applies innovative computational technologies for the design, selection, and optimization of novel drug candidates | Commercial Services |
ArQule UK Ltd.
 ArQule UK Ltd. Pharmaceuticals: MajorHealth Technology Discovers and produces novel chemical compounds with commercial potential | Health Technology |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that manufactures and wholesales prescription medicine products | Health Technology |
Protagonist Therapeutics, Inc.
 Protagonist Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures peptide based therapeutic products | Health Technology |
Amunix, Inc.
 Amunix, Inc. Pharmaceuticals: MajorHealth Technology Develops protein pharmaceuticals | Health Technology |
Mission Bay Capital Management, Inc.
Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital invests in companies located in the United States. The firm focuses on the biotechnology and life sciences sector. It participates in early stage capital transactions. Mission Bay Capital reorganized its operating segments on January 21,2020, by combining BioInnovation Management LLC and Mission Bay Capital Management Inc into a single segment called - Mission BioCapital. | Finance |
Catalyst Biosciences, Inc.
 Catalyst Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Camitro UK Ltd.
 Camitro UK Ltd. Miscellaneous Commercial ServicesCommercial Services Operates commercial research institutions | Commercial Services |
Molecular Templates, Inc.
 Molecular Templates, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Commercial Services |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops transformative T cell engagers (TCEs) and cytokine therapies for patients with cancer | Health Technology |
Hinge Bio, Inc.
Hinge Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for autoimmune and inflammatory & cancer diseases | Health Technology |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
